1. 314PAssociation of immune-related adverse events and efficacy in Japanese patients with squamous cell carcinoma of the head and neck treated with nivolumab. (25th November 2018) Authors: Otsuka, T; Fujiishi, K; Matsumoto, K; Kimura, T; Koike, R; Cho, H; Hasegawa, A; Nishio, M; Otozai, S; Yoshii, T; Kudo, T; Fujisawa, F; Sugimoto, N; Yagi, T; Imamura, F; Fujii, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endothelial dysfunction and cardiovascular mortality in patients with acute coronary syndrome. (25th November 2020) Authors: Yoshii, T; Matsuzawa, T; Nakahashi, H; Satou, R; Akiyama, E; Kimura, Y; Okada, K; Maejima, N; Iwahashi, N; Hibi, K; Kosuge, M; Ebina, T; Kimura, K; Tamura, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inflammation-frailty linkage and its long-term prognostic impact in patients with acute coronary syndrome. (14th October 2021) Authors: Satou, R; Matsuzawa, Y; Akiyama, E; Konishi, M; Yoshii, T; Nakahashi, H; Minamimoto, Y; Okada, K; Maejima, N; Iwahashi, N; Hibi, K; Kosuge, M; Ebina, T; Tamura, K; Kimura, K Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-density lipoprotein cholesterol levels on admission and long-term outcomes in statin-naive patients with acute coronary syndrome. (25th November 2020) Authors: Satou, R; Matsuzawa, Y; Akiyama, E; Konishi, M; Yoshii, T; Okada, K; Maejima, N; Iwahashi, N; Hibi, K; Kosuge, M; Ebina, T; Tamura, K; Kimura, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SO-007Regorafenib plus nivolumab in patients with advanced colorectal or gastric cancer: an open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603). (2nd July 2019) Authors: Hara, H; Fukuoka, S; Takahashi, N; Kojima, T; Kawazoe, A; Asayama, M; Yoshii, T; Kotani, D; Tamura, H; Mikamoto, Y; Sugama, A; Wakabayashi, M; Nomura, S; Sato, A; Togashi, Y; Nishikawa, H; Shitara, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗